المؤلفون: Odilon Nouatin (828356), Juliana Boex Mengue (10906209), Jean Claude Dejon-Agobé (5598059), Rolf Fendel (211799), Javier Ibáñez (3450593), Ulysse Ateba Ngoa (10906212), Jean Ronald Edoa (10881610), Bayodé Roméo Adégbité (10906215), Yabo Josiane Honkpéhédji (10906218), Jeannot Fréjus Zinsou (5598062), Aurore Bouyoukou Hounkpatin (10906221), Kabirou Moutairou (828360), Andreas Homoet (10906224), Meral Esen (211790), Andrea Kreidenweiss (365793), Stephen L. Hoffman (10038985), Michael Theisen (81720), Adrian J. F. Luty (7910207), Bertrand Lell (224978), Selidji Todagbe Agnandji (3358820), Ghyslain Mombo-Ngoma (265164), Michael Ramharter (297552), Peter Kremsner (229101), Benjamin Mordmüller (211841), Ayôla Akim Adegnika (5598074)

مصطلحات موضوعية: Medicine, Microbiology, Cell Biology, Biotechnology, Immunology, Cancer, Infectious Diseases, Virology, Computational Biology, Physical Sciences not elsewhere classified, CHMI, Total vaccine-specific IgG concentr., Vaccine-specific antibody concentra., 35 days, helminth infection, PCR, DVI, efficacy, polymerase chain reaction, falciparum, GLURP, Cationic Adjuvant Formulation, malaria-exposed adult volunteers, asexual blood-stage malaria vaccine., GMZ 2 adjuvanted, MSP, asexual blood-stage antigens, CAF, GMZ 2 malaria vaccine candidate, anti-GMZ 2 IgG concentration

Relation: https://figshare.com/articles/journal_contribution/PCR_mix_optimized_for_our_Study_/14713113

الاتاحة: https://doi.org/10.1371/journal.pntd.0009361.s002

المؤلفون: Odilon Nouatin (828356), Juliana Boex Mengue (10906209), Jean Claude Dejon-Agobé (5598059), Rolf Fendel (211799), Javier Ibáñez (3450593), Ulysse Ateba Ngoa (10906212), Jean Ronald Edoa (10881610), Bayodé Roméo Adégbité (10906215), Yabo Josiane Honkpéhédji (10906218), Jeannot Fréjus Zinsou (5598062), Aurore Bouyoukou Hounkpatin (10906221), Kabirou Moutairou (828360), Andreas Homoet (10906224), Meral Esen (211790), Andrea Kreidenweiss (365793), Stephen L. Hoffman (10038985), Michael Theisen (81720), Adrian J. F. Luty (7910207), Bertrand Lell (224978), Selidji Todagbe Agnandji (3358820), Ghyslain Mombo-Ngoma (265164), Michael Ramharter (297552), Peter Kremsner (229101), Benjamin Mordmüller (211841), Ayôla Akim Adegnika (5598074)

مصطلحات موضوعية: Medicine, Microbiology, Cell Biology, Biotechnology, Immunology, Cancer, Infectious Diseases, Virology, Computational Biology, Physical Sciences not elsewhere classified, CHMI, Total vaccine-specific IgG concentr., Vaccine-specific antibody concentra., 35 days, helminth infection, PCR, DVI, efficacy, polymerase chain reaction, falciparum, GLURP, Cationic Adjuvant Formulation, malaria-exposed adult volunteers, asexual blood-stage malaria vaccine., GMZ 2 adjuvanted, MSP, asexual blood-stage antigens, CAF, GMZ 2 malaria vaccine candidate, anti-GMZ 2 IgG concentration

Relation: https://figshare.com/articles/journal_contribution/Oligonucleotides_List_for_the_real_time_amplification_/14713110

الاتاحة: https://doi.org/10.1371/journal.pntd.0009361.s001

المؤلفون: Odilon Nouatin (828356), Juliana Boex Mengue (10906209), Jean Claude Dejon-Agobé (5598059), Rolf Fendel (211799), Javier Ibáñez (3450593), Ulysse Ateba Ngoa (10906212), Jean Ronald Edoa (10881610), Bayodé Roméo Adégbité (10906215), Yabo Josiane Honkpéhédji (10906218), Jeannot Fréjus Zinsou (5598062), Aurore Bouyoukou Hounkpatin (10906221), Kabirou Moutairou (828360), Andreas Homoet (10906224), Meral Esen (211790), Andrea Kreidenweiss (365793), Stephen L. Hoffman (10038985), Michael Theisen (81720), Adrian J. F. Luty (7910207), Bertrand Lell (224978), Selidji Todagbe Agnandji (3358820), Ghyslain Mombo-Ngoma (265164), Michael Ramharter (297552), Peter Kremsner (229101), Benjamin Mordmüller (211841), Ayôla Akim Adegnika (5598074)

مصطلحات موضوعية: Medicine, Microbiology, Cell Biology, Biotechnology, Immunology, Cancer, Infectious Diseases, Virology, Computational Biology, Physical Sciences not elsewhere classified, CHMI, Total vaccine-specific IgG concentr., Vaccine-specific antibody concentra., 35 days, helminth infection, PCR, DVI, efficacy, polymerase chain reaction, falciparum, GLURP, Cationic Adjuvant Formulation, malaria-exposed adult volunteers, asexual blood-stage malaria vaccine., GMZ 2 adjuvanted, MSP, asexual blood-stage antigens, CAF, GMZ 2 malaria vaccine candidate, anti-GMZ 2 IgG concentration

Relation: https://figshare.com/articles/journal_contribution/Distribution_of_helminth_species_in_the_helminth_co-infected_group_in_individuals_who_did_or_did_not_develop_malaria_following_CHMI_/14713122

الاتاحة: https://doi.org/10.1371/journal.pntd.0009361.s004

المؤلفون: Odilon Nouatin (828356), Juliana Boex Mengue (10906209), Jean Claude Dejon-Agobé (5598059), Rolf Fendel (211799), Javier Ibáñez (3450593), Ulysse Ateba Ngoa (10906212), Jean Ronald Edoa (10881610), Bayodé Roméo Adégbité (10906215), Yabo Josiane Honkpéhédji (10906218), Jeannot Fréjus Zinsou (5598062), Aurore Bouyoukou Hounkpatin (10906221), Kabirou Moutairou (828360), Andreas Homoet (10906224), Meral Esen (211790), Andrea Kreidenweiss (365793), Stephen L. Hoffman (10038985), Michael Theisen (81720), Adrian J. F. Luty (7910207), Bertrand Lell (224978), Selidji Todagbe Agnandji (3358820), Ghyslain Mombo-Ngoma (265164), Michael Ramharter (297552), Peter Kremsner (229101), Benjamin Mordmüller (211841), Ayôla Akim Adegnika (5598074)

مصطلحات موضوعية: Medicine, Microbiology, Cell Biology, Biotechnology, Immunology, Cancer, Infectious Diseases, Virology, Computational Biology, Physical Sciences not elsewhere classified, CHMI, Total vaccine-specific IgG concentr., Vaccine-specific antibody concentra., 35 days, helminth infection, PCR, DVI, efficacy, polymerase chain reaction, falciparum, GLURP, Cationic Adjuvant Formulation, malaria-exposed adult volunteers, asexual blood-stage malaria vaccine., GMZ 2 adjuvanted, MSP, asexual blood-stage antigens, CAF, GMZ 2 malaria vaccine candidate, anti-GMZ 2 IgG concentration

Relation: https://figshare.com/articles/journal_contribution/Proportion_of_helminth_species_in_coinfected_groups_at_D0_and_or_at_D84_/14713119

الاتاحة: https://doi.org/10.1371/journal.pntd.0009361.s003

المؤلفون: Odilon Nouatin (828356), Juliana Boex Mengue (10906209), Jean Claude Dejon-Agobé (5598059), Rolf Fendel (211799), Javier Ibáñez (3450593), Ulysse Ateba Ngoa (10906212), Jean Ronald Edoa (10881610), Bayodé Roméo Adégbité (10906215), Yabo Josiane Honkpéhédji (10906218), Jeannot Fréjus Zinsou (5598062), Aurore Bouyoukou Hounkpatin (10906221), Kabirou Moutairou (828360), Andreas Homoet (10906224), Meral Esen (211790), Andrea Kreidenweiss (365793), Stephen L. Hoffman (10038985), Michael Theisen (81720), Adrian J. F. Luty (7910207), Bertrand Lell (224978), Selidji Todagbe Agnandji (3358820), Ghyslain Mombo-Ngoma (265164), Michael Ramharter (297552), Peter Kremsner (229101), Benjamin Mordmüller (211841), Ayôla Akim Adegnika (5598074)

مصطلحات موضوعية: Medicine, Microbiology, Cell Biology, Biotechnology, Immunology, Cancer, Infectious Diseases, Virology, Computational Biology, Physical Sciences not elsewhere classified, CHMI, Total vaccine-specific IgG concentr., Vaccine-specific antibody concentra., 35 days, helminth infection, PCR, DVI, efficacy, polymerase chain reaction, falciparum, GLURP, Cationic Adjuvant Formulation, malaria-exposed adult volunteers, asexual blood-stage malaria vaccine., GMZ 2 adjuvanted, MSP, asexual blood-stage antigens, CAF, GMZ 2 malaria vaccine candidate, anti-GMZ 2 IgG concentration

Relation: https://figshare.com/articles/journal_contribution/_i_Schistosoma_haematobium_i_egg_counts_per_subject_in_infected_volunteers_/14713125

الاتاحة: https://doi.org/10.1371/journal.pntd.0009361.s005

المؤلفون: Odilon Nouatin (828356), Juliana Boex Mengue (10906209), Jean Claude Dejon-Agobé (5598059), Rolf Fendel (211799), Javier Ibáñez (3450593), Ulysse Ateba Ngoa (10906212), Jean Ronald Edoa (10881610), Bayodé Roméo Adégbité (10906215), Yabo Josiane Honkpéhédji (10906218), Jeannot Fréjus Zinsou (5598062), Aurore Bouyoukou Hounkpatin (10906221), Kabirou Moutairou (828360), Andreas Homoet (10906224), Meral Esen (211790), Andrea Kreidenweiss (365793), Stephen L. Hoffman (10038985), Michael Theisen (81720), Adrian J. F. Luty (7910207), Bertrand Lell (224978), Selidji Todagbe Agnandji (3358820), Ghyslain Mombo-Ngoma (265164), Michael Ramharter (297552), Peter Kremsner (229101), Benjamin Mordmüller (211841), Ayôla Akim Adegnika (5598074)

مصطلحات موضوعية: Medicine, Microbiology, Cell Biology, Biotechnology, Immunology, Cancer, Infectious Diseases, Virology, Computational Biology, Physical Sciences not elsewhere classified, CHMI, Total vaccine-specific IgG concentr., Vaccine-specific antibody concentra., 35 days, helminth infection, PCR, DVI, efficacy, polymerase chain reaction, falciparum, GLURP, Cationic Adjuvant Formulation, malaria-exposed adult volunteers, asexual blood-stage malaria vaccine., GMZ 2 adjuvanted, MSP, asexual blood-stage antigens, CAF, GMZ 2 malaria vaccine candidate, anti-GMZ 2 IgG concentration

Relation: https://figshare.com/articles/dataset/Data_underlying_the_findings_/14713137

الاتاحة: https://doi.org/10.1371/journal.pntd.0009361.s008

المؤلفون: Odilon Nouatin (828356), Juliana Boex Mengue (10906209), Jean Claude Dejon-Agobé (5598059), Rolf Fendel (211799), Javier Ibáñez (3450593), Ulysse Ateba Ngoa (10906212), Jean Ronald Edoa (10881610), Bayodé Roméo Adégbité (10906215), Yabo Josiane Honkpéhédji (10906218), Jeannot Fréjus Zinsou (5598062), Aurore Bouyoukou Hounkpatin (10906221), Kabirou Moutairou (828360), Andreas Homoet (10906224), Meral Esen (211790), Andrea Kreidenweiss (365793), Stephen L. Hoffman (10038985), Michael Theisen (81720), Adrian J. F. Luty (7910207), Bertrand Lell (224978), Selidji Todagbe Agnandji (3358820), Ghyslain Mombo-Ngoma (265164), Michael Ramharter (297552), Peter Kremsner (229101), Benjamin Mordmüller (211841), Ayôla Akim Adegnika (5598074)

مصطلحات موضوعية: Medicine, Microbiology, Cell Biology, Biotechnology, Immunology, Cancer, Infectious Diseases, Virology, Computational Biology, Physical Sciences not elsewhere classified, CHMI, Total vaccine-specific IgG concentr., Vaccine-specific antibody concentra., 35 days, helminth infection, PCR, DVI, efficacy, polymerase chain reaction, falciparum, GLURP, Cationic Adjuvant Formulation, malaria-exposed adult volunteers, asexual blood-stage malaria vaccine., GMZ 2 adjuvanted, MSP, asexual blood-stage antigens, CAF, GMZ 2 malaria vaccine candidate, anti-GMZ 2 IgG concentration

Relation: https://figshare.com/articles/figure/S2_Fig_-/14713134

الاتاحة: https://doi.org/10.1371/journal.pntd.0009361.s007

المؤلفون: Odilon Nouatin (828356), Juliana Boex Mengue (10906209), Jean Claude Dejon-Agobé (5598059), Rolf Fendel (211799), Javier Ibáñez (3450593), Ulysse Ateba Ngoa (10906212), Jean Ronald Edoa (10881610), Bayodé Roméo Adégbité (10906215), Yabo Josiane Honkpéhédji (10906218), Jeannot Fréjus Zinsou (5598062), Aurore Bouyoukou Hounkpatin (10906221), Kabirou Moutairou (828360), Andreas Homoet (10906224), Meral Esen (211790), Andrea Kreidenweiss (365793), Stephen L. Hoffman (10038985), Michael Theisen (81720), Adrian J. F. Luty (7910207), Bertrand Lell (224978), Selidji Todagbe Agnandji (3358820), Ghyslain Mombo-Ngoma (265164), Michael Ramharter (297552), Peter Kremsner (229101), Benjamin Mordmüller (211841), Ayôla Akim Adegnika (5598074)

مصطلحات موضوعية: Medicine, Microbiology, Cell Biology, Biotechnology, Immunology, Cancer, Infectious Diseases, Virology, Computational Biology, Physical Sciences not elsewhere classified, CHMI, Total vaccine-specific IgG concentr., Vaccine-specific antibody concentra., 35 days, helminth infection, PCR, DVI, efficacy, polymerase chain reaction, falciparum, GLURP, Cationic Adjuvant Formulation, malaria-exposed adult volunteers, asexual blood-stage malaria vaccine., GMZ 2 adjuvanted, MSP, asexual blood-stage antigens, CAF, GMZ 2 malaria vaccine candidate, anti-GMZ 2 IgG concentration

Relation: https://figshare.com/articles/figure/Flow_chart_of_the_study_participants_/14713143

الاتاحة: https://doi.org/10.1371/journal.pntd.0009361.g001

المؤلفون: Odilon Nouatin (828356), Juliana Boex Mengue (10906209), Jean Claude Dejon-Agobé (5598059), Rolf Fendel (211799), Javier Ibáñez (3450593), Ulysse Ateba Ngoa (10906212), Jean Ronald Edoa (10881610), Bayodé Roméo Adégbité (10906215), Yabo Josiane Honkpéhédji (10906218), Jeannot Fréjus Zinsou (5598062), Aurore Bouyoukou Hounkpatin (10906221), Kabirou Moutairou (828360), Andreas Homoet (10906224), Meral Esen (211790), Andrea Kreidenweiss (365793), Stephen L. Hoffman (10038985), Michael Theisen (81720), Adrian J. F. Luty (7910207), Bertrand Lell (224978), Selidji Todagbe Agnandji (3358820), Ghyslain Mombo-Ngoma (265164), Michael Ramharter (297552), Peter Kremsner (229101), Benjamin Mordmüller (211841), Ayôla Akim Adegnika (5598074)

مصطلحات موضوعية: Medicine, Microbiology, Cell Biology, Biotechnology, Immunology, Cancer, Infectious Diseases, Virology, Computational Biology, Physical Sciences not elsewhere classified, CHMI, Total vaccine-specific IgG concentr., Vaccine-specific antibody concentra., 35 days, helminth infection, PCR, DVI, efficacy, polymerase chain reaction, falciparum, GLURP, Cationic Adjuvant Formulation, malaria-exposed adult volunteers, asexual blood-stage malaria vaccine., GMZ 2 adjuvanted, MSP, asexual blood-stage antigens, CAF, GMZ 2 malaria vaccine candidate, anti-GMZ 2 IgG concentration

Relation: https://figshare.com/articles/figure/Anti-GMZ2_IgG_concentration_and_CHMI_outcome_groups_according_to_helminth_status_Comparison_of_vaccine-specific_total_IgG_concentration_at_D84_between_those_having_clinical_malaria_monotone_increase_of_parasitemia_with_symptoms_and_those_wi/14713158

الاتاحة: https://doi.org/10.1371/journal.pntd.0009361.g005

المؤلفون: Odilon Nouatin (828356), Juliana Boex Mengue (10906209), Jean Claude Dejon-Agobé (5598059), Rolf Fendel (211799), Javier Ibáñez (3450593), Ulysse Ateba Ngoa (10906212), Jean Ronald Edoa (10881610), Bayodé Roméo Adégbité (10906215), Yabo Josiane Honkpéhédji (10906218), Jeannot Fréjus Zinsou (5598062), Aurore Bouyoukou Hounkpatin (10906221), Kabirou Moutairou (828360), Andreas Homoet (10906224), Meral Esen (211790), Andrea Kreidenweiss (365793), Stephen L. Hoffman (10038985), Michael Theisen (81720), Adrian J. F. Luty (7910207), Bertrand Lell (224978), Selidji Todagbe Agnandji (3358820), Ghyslain Mombo-Ngoma (265164), Michael Ramharter (297552), Peter Kremsner (229101), Benjamin Mordmüller (211841), Ayôla Akim Adegnika (5598074)

مصطلحات موضوعية: Medicine, Microbiology, Cell Biology, Biotechnology, Immunology, Cancer, Infectious Diseases, Virology, Computational Biology, Physical Sciences not elsewhere classified, CHMI, Total vaccine-specific IgG concentr., Vaccine-specific antibody concentra., 35 days, helminth infection, PCR, DVI, efficacy, polymerase chain reaction, falciparum, GLURP, Cationic Adjuvant Formulation, malaria-exposed adult volunteers, asexual blood-stage malaria vaccine., GMZ 2 adjuvanted, MSP, asexual blood-stage antigens, CAF, GMZ 2 malaria vaccine candidate, anti-GMZ 2 IgG concentration

Relation: https://figshare.com/articles/figure/Post_immunization_antibody_concentration_at_D84_in_helminth_uninfected_and_infected_groups_Helm-_and_Helm_/14713146

الاتاحة: https://doi.org/10.1371/journal.pntd.0009361.g002

المؤلفون: Odilon Nouatin (828356), Juliana Boex Mengue (10906209), Jean Claude Dejon-Agobé (5598059), Rolf Fendel (211799), Javier Ibáñez (3450593), Ulysse Ateba Ngoa (10906212), Jean Ronald Edoa (10881610), Bayodé Roméo Adégbité (10906215), Yabo Josiane Honkpéhédji (10906218), Jeannot Fréjus Zinsou (5598062), Aurore Bouyoukou Hounkpatin (10906221), Kabirou Moutairou (828360), Andreas Homoet (10906224), Meral Esen (211790), Andrea Kreidenweiss (365793), Stephen L. Hoffman (10038985), Michael Theisen (81720), Adrian J. F. Luty (7910207), Bertrand Lell (224978), Selidji Todagbe Agnandji (3358820), Ghyslain Mombo-Ngoma (265164), Michael Ramharter (297552), Peter Kremsner (229101), Benjamin Mordmüller (211841), Ayôla Akim Adegnika (5598074)

مصطلحات موضوعية: Medicine, Microbiology, Cell Biology, Biotechnology, Immunology, Cancer, Infectious Diseases, Virology, Computational Biology, Physical Sciences not elsewhere classified, CHMI, Total vaccine-specific IgG concentr., Vaccine-specific antibody concentra., 35 days, helminth infection, PCR, DVI, efficacy, polymerase chain reaction, falciparum, GLURP, Cationic Adjuvant Formulation, malaria-exposed adult volunteers, asexual blood-stage malaria vaccine., GMZ 2 adjuvanted, MSP, asexual blood-stage antigens, CAF, GMZ 2 malaria vaccine candidate, anti-GMZ 2 IgG concentration

Relation: https://figshare.com/articles/figure/Post_immunization_antibody_concentration_at_D84_in_Helm-_and_Helm_subgroups_/14713152

الاتاحة: https://doi.org/10.1371/journal.pntd.0009361.g003

المؤلفون: Odilon Nouatin (828356), Juliana Boex Mengue (10906209), Jean Claude Dejon-Agobé (5598059), Rolf Fendel (211799), Javier Ibáñez (3450593), Ulysse Ateba Ngoa (10906212), Jean Ronald Edoa (10881610), Bayodé Roméo Adégbité (10906215), Yabo Josiane Honkpéhédji (10906218), Jeannot Fréjus Zinsou (5598062), Aurore Bouyoukou Hounkpatin (10906221), Kabirou Moutairou (828360), Andreas Homoet (10906224), Meral Esen (211790), Andrea Kreidenweiss (365793), Stephen L. Hoffman (10038985), Michael Theisen (81720), Adrian J. F. Luty (7910207), Bertrand Lell (224978), Selidji Todagbe Agnandji (3358820), Ghyslain Mombo-Ngoma (265164), Michael Ramharter (297552), Peter Kremsner (229101), Benjamin Mordmüller (211841), Ayôla Akim Adegnika (5598074)

مصطلحات موضوعية: Medicine, Microbiology, Cell Biology, Biotechnology, Immunology, Cancer, Infectious Diseases, Virology, Computational Biology, Physical Sciences not elsewhere classified, CHMI, Total vaccine-specific IgG concentr., Vaccine-specific antibody concentra., 35 days, helminth infection, PCR, DVI, efficacy, polymerase chain reaction, falciparum, GLURP, Cationic Adjuvant Formulation, malaria-exposed adult volunteers, asexual blood-stage malaria vaccine., GMZ 2 adjuvanted, MSP, asexual blood-stage antigens, CAF, GMZ 2 malaria vaccine candidate, anti-GMZ 2 IgG concentration

Relation: https://figshare.com/articles/dataset/Comparison_of_antibody_log_concentrations_mean_SD_between_helminth_infection_groups_at_D84_stratified_by_study_vaccination_groups_/14713167

الاتاحة: https://doi.org/10.1371/journal.pntd.0009361.t002

المؤلفون: Odilon Nouatin (828356), Juliana Boex Mengue (10906209), Jean Claude Dejon-Agobé (5598059), Rolf Fendel (211799), Javier Ibáñez (3450593), Ulysse Ateba Ngoa (10906212), Jean Ronald Edoa (10881610), Bayodé Roméo Adégbité (10906215), Yabo Josiane Honkpéhédji (10906218), Jeannot Fréjus Zinsou (5598062), Aurore Bouyoukou Hounkpatin (10906221), Kabirou Moutairou (828360), Andreas Homoet (10906224), Meral Esen (211790), Andrea Kreidenweiss (365793), Stephen L. Hoffman (10038985), Michael Theisen (81720), Adrian J. F. Luty (7910207), Bertrand Lell (224978), Selidji Todagbe Agnandji (3358820), Ghyslain Mombo-Ngoma (265164), Michael Ramharter (297552), Peter Kremsner (229101), Benjamin Mordmüller (211841), Ayôla Akim Adegnika (5598074)

مصطلحات موضوعية: Medicine, Microbiology, Cell Biology, Biotechnology, Immunology, Cancer, Infectious Diseases, Virology, Computational Biology, Physical Sciences not elsewhere classified, CHMI, Total vaccine-specific IgG concentr., Vaccine-specific antibody concentra., 35 days, helminth infection, PCR, DVI, efficacy, polymerase chain reaction, falciparum, GLURP, Cationic Adjuvant Formulation, malaria-exposed adult volunteers, asexual blood-stage malaria vaccine., GMZ 2 adjuvanted, MSP, asexual blood-stage antigens, CAF, GMZ 2 malaria vaccine candidate, anti-GMZ 2 IgG concentration

Relation: https://figshare.com/articles/dataset/Characteristics_and_hematological_profile_of_the_study_population_on_D84_with_regard_to_helminth_status_/14713164

الاتاحة: https://doi.org/10.1371/journal.pntd.0009361.t001